IRIS Accounts Production v26.2.0.496 03809089 director 1.1.25 31.12.25 31.12.25 21.9.26 false true false false true false Auditors Opinion Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh038090892024-12-31038090892025-12-31038090892025-01-012025-12-31038090892023-12-31038090892024-01-012024-12-31038090892024-12-3103809089ns15:EnglandWales2025-01-012025-12-3103809089ns14:PoundSterling2025-01-012025-12-3103809089ns10:Director12025-01-012025-12-3103809089ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3103809089ns10:SmallEntities2025-01-012025-12-3103809089ns10:Audited2025-01-012025-12-3103809089ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3103809089ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3103809089ns10:FullAccounts2025-01-012025-12-3103809089ns10:OrdinaryShareClass12025-01-012025-12-3103809089ns10:CompanySecretary12025-01-012025-12-3103809089ns10:RegisteredOffice2025-01-012025-12-3103809089ns5:CurrentFinancialInstruments2025-12-3103809089ns5:CurrentFinancialInstruments2024-12-3103809089ns5:ShareCapital2025-12-3103809089ns5:ShareCapital2024-12-3103809089ns5:RetainedEarningsAccumulatedLosses2025-12-3103809089ns5:RetainedEarningsAccumulatedLosses2024-12-3103809089ns5:ComputerEquipment2025-01-012025-12-3103809089ns5:ComputerEquipment2024-12-3103809089ns5:ComputerEquipment2025-12-3103809089ns5:ComputerEquipment2024-12-3103809089ns5:AcceleratedTaxDepreciationDeferredTax2025-12-3103809089ns5:AcceleratedTaxDepreciationDeferredTax2024-12-3103809089ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3103809089ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3103809089ns5:DeferredTaxation2024-12-3103809089ns5:DeferredTaxation2025-01-012025-12-3103809089ns5:DeferredTaxation2025-12-3103809089ns10:OrdinaryShareClass12025-12-31
REGISTERED NUMBER: 03809089 (England and Wales)















AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

K2 MEDICAL SYSTEMS LIMITED

K2 MEDICAL SYSTEMS LIMITED (REGISTERED NUMBER: 03809089)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


K2 MEDICAL SYSTEMS LIMITED

COMPANY INFORMATION
for the Year Ended 31 December 2025







DIRECTOR: Mr J Bender





SECRETARY: Mr J A Evans





REGISTERED OFFICE: Brooke Suite
Ground Floor Bewley House
Marshfield Road
Chippenham
SN15 1JW





REGISTERED NUMBER: 03809089 (England and Wales)





AUDITORS: Kings CAP Ltd
Statutory Auditor
4 Grovelands
Boundary Way
Hemel Hempstead
Hertfordshire
HP2 7TE

K2 MEDICAL SYSTEMS LIMITED (REGISTERED NUMBER: 03809089)

BALANCE SHEET
31 December 2025

31.12.25 31.12.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 26,688 15,884

CURRENT ASSETS
Stocks 5 451,831 410,820
Debtors 6 6,030,613 5,241,269
Cash at bank 371,136 256,173
6,853,580 5,908,262
CREDITORS
Amounts falling due within one year 7 5,265,441 5,910,365
NET CURRENT ASSETS/(LIABILITIES) 1,588,139 (2,103 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,614,827

13,781

PROVISIONS FOR LIABILITIES 8 6,672 -
NET ASSETS 1,608,155 13,781

CAPITAL AND RESERVES
Called up share capital 9 47 47
Retained earnings 1,608,108 13,734
SHAREHOLDERS' FUNDS 1,608,155 13,781

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 September 2026 and were signed by:





Mr J Bender - Director


K2 MEDICAL SYSTEMS LIMITED (REGISTERED NUMBER: 03809089)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

K2 Medical Systems Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company's going concern status is dependent upon the continued financial support of the parent undertaking. Having made appropriate enquiries at the time of approving these accounts the director considers that the company and the parent undertaking have adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis in preparing these accounts.

Preparation of consolidated financial statements
The financial statements contain information about K2 Medical Systems Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 400 of the Companies Act 2006 from the requirements to prepare consolidated financial statements as it and its subsidiary undertaking are included by full consolidation in the consolidated financial statements of its parent, Constellation Software Inc., 66 Wellington Street West, Suite 5300, TD Bank Tower, Toronto, Ontario, M5K 1E6.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on cost

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

The cost of finished goods and work in progress comprises direct materials only. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit and loss.

K2 MEDICAL SYSTEMS LIMITED (REGISTERED NUMBER: 03809089)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

K2 MEDICAL SYSTEMS LIMITED (REGISTERED NUMBER: 03809089)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2025

2. ACCOUNTING POLICIES - continued

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 38 (2024 - 41 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 January 2025 64,697
Additions 33,056
Disposals (53,356 )
At 31 December 2025 44,397
DEPRECIATION
At 1 January 2025 48,813
Charge for year 15,263
Eliminated on disposal (46,367 )
At 31 December 2025 17,709
NET BOOK VALUE
At 31 December 2025 26,688
At 31 December 2024 15,884

5. STOCKS
31.12.25 31.12.24
£    £   
Work-in-progress 451,831 410,820

K2 MEDICAL SYSTEMS LIMITED (REGISTERED NUMBER: 03809089)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2025

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Trade debtors 342,451 210,962
Amounts owed by group undertakings 5,481,681 4,675,379
Other debtors 162,794 67,013
Tax - 2,636
Deferred tax asset
Accelerated capital allowances - 258,848
Prepayments 43,687 26,431
6,030,613 5,241,269

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Trade creditors 9,577 22,882
Amounts owed to group undertakings 3,133,383 3,382,138
Taxation 266,081 -
Social security and other taxes 56,210 -
Value added tax 72,810 156,032
Other creditors 22,388 14,579
Accruals and deferred income 1,540,625 2,145,274
Accruals 164,367 189,460
5,265,441 5,910,365

8. PROVISIONS FOR LIABILITIES
31.12.25
£   
Deferred tax
Accelerated capital allowances 6,672

Deferred
tax
£   
Balance at 1 January 2025 (258,848 )
Charge to Statement of Income and Retained Earnings during year 265,520
Balance at 31 December 2025 6,672

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.25 31.12.24
value: £    £   
4,772 Ordinary £0.01 47 47

K2 MEDICAL SYSTEMS LIMITED (REGISTERED NUMBER: 03809089)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2025

10. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Sara Brown (Senior Statutory Auditor)
for and on behalf of Kings CAP Ltd

11. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Constellation Software Inc..

The ultimate controlling party address is 66 Wellington Street West, Suite 5300, TD Bank Tower, Toronto, Ontario, M5K 1E6. The company is registered in Canada.

The parent company is K2 Medical Systems Holdings Ltd, Brooke Suite, Ground Floor Bewley House, Marshfield Road, Chippenham, SN15 1JW. The company is registered in the UK.